Trial data disclosure: cautious industry backs widespread publication strategy
This article was originally published in Scrip
Executive Summary
Amid all the debate over improving trial data disclosure, companies and clinical research organisations, appear to be still treading very cautiously towards endorsing suggestions that all trial data, past and present, and their results be reported.